Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America
Timely, relevant discussions on breast cancer
Harold J. Burstein (Edited by)
9780443181856, Elsevier Health Sciences
Hardback, published 29 November 2022
240 pages
22.9 x 15.1 x 2.1 cm, 0.54 kg
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more. Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more. Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Disparities in Breast Cancer Outcomes and How to Resolve Them Testing for Inherited Susceptibility to Breast Cancer Breast Cancer Pathology in the Era of Genomics Breast Cancer Pathology in the Era of Genomics Role of Ovarian Suppression in Early Premenopausal Breast Cancer Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer Biology and Treatment of HER2-Low Breast Cancer Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Multidisciplinary Management of Brain Metastasis from Breast Cancer Systemic Therapy for Hereditary Breast Cancers Evidence-Based Guidance for Breast Cancer Survivorship
Subject Areas: Oncology [MJCL]
